ResMed reported strong financial performance with significant revenue growth, gross margin expansion, and strategic acquisitions. The company is well-positioned with a strong balance sheet and operational excellence. However, challenges such as competitive bidding concerns and market challenges in China remain. Despite these challenges, the overall sentiment is positive due to the strong highlights.

Company Guidance -

Q1 2026

During the ResMed Q4 Fiscal Year 2025 earnings call, the company reported robust financial results, including a 10% year-over-year revenue growth and a 230 basis points expansion in gross margin. The fiscal year 2025 free cash flow was $1.7 billion, and ResMed returned over $610 million to shareholders through dividends and share repurchases. The company is focused on reaching its 2030 goal of improving over 500 million people's lives and is currently serving more than 154 million lives globally. ResMed plans to continue investing in research and development, operational excellence, and strategic acquisitions, such as VirtuOx, to enhance its digital health ecosystem. The company also announced an increase in the quarterly dividend for fiscal year 2026 and plans to significantly increase its share repurchase activities. ResMed's gross margin for fiscal year 2025 was 61.4%, and the company expects it to be in the range of 61% to 63% in fiscal year 2026, driven by procurement, manufacturing, and logistics efficiencies.

Strong Revenue Growth

Achieved 10% year-over-year reported revenue growth and 230 basis points of year-over-year gross margin expansion in Q4 FY2025.

Free Cash Flow and Balance Sheet

Fiscal year 2025 free cash flow was $1.7 billion, providing significant flexibility for investments and capital returns.

Dividend and Share Buyback Increase

Board authorized a 13% increase in the quarterly dividend for FY2026 and plans to significantly increase share repurchase activity.

Operational Excellence

Achieved 230 basis points of gross margin expansion year-over-year in Q4, with ongoing pipeline opportunities for further improvements.

Expansion in Digital Health Ecosystem

Continued expansion of digital health ecosystem, now serving over 154 million lives with a goal to improve over 500 million lives by 2030.

Acquisition Strategy

Recent acquisitions, including VirtuOx, are expected to help move more patients through the sleep care funnel efficiently.

R&D and Innovation

Continued investment in R&D with a focus on AI and GenAI technology to enhance personalized health care solutions.

Resmed (RMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

RMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2026 (Q1)	2.52 / -	2.2	―	―	―
Jul 31, 2025	2025 (Q4)	2.55 / 2.55	2.08	22.60% (+0.47)
Apr 23, 2025	2025 (Q3)	2.38 / 2.37	2.13	11.27% (+0.24)
Jan 30, 2025	2025 (Q2)	2.32 / 2.43	1.88	29.26% (+0.55)
Oct 24, 2024	2025 (Q1)	2.05 / 2.20	1.64	34.15% (+0.56)
Aug 01, 2024	2024 (Q4)	2.08 / 2.08	1.6	30.00% (+0.48)
Apr 25, 2024	2024 (Q3)	1.93 / 2.13	1.68	26.79% (+0.45)
Jan 24, 2024	2024 (Q2)	1.78 / 1.88	1.66	13.25% (+0.22)
Oct 26, 2023	2024 (Q1)	1.62 / 1.64	1.51	8.61% (+0.13)
Aug 03, 2023	2023 (Q4)	1.68 / 1.60	1.49	7.38% (+0.11)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

RMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$271.37	$278.62	+2.67%
Apr 23, 2025	$213.53	$235.10	+10.10%
Jan 30, 2025	$255.98	$234.65	-8.33%
Oct 24, 2024	$236.99	$253.86	+7.12%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Resmed (RMD) report earnings?

Resmed (RMD) is schdueled to report earning on Oct 23, 2025, After Close (Confirmed).

What is Resmed (RMD) earnings time?

Resmed (RMD) earnings time is at Oct 23, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is RMD EPS forecast?

RMD EPS forecast for the fiscal quarter 2026 (Q1) is 2.52.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing